Abstract:Extracellular vesicles (EVs) are a kind of heterogeneous vesicles released by essentially all cell types, which plays an important role in intercellular communication and in the regulation of physiological process (or pathology). EVs mainly includes microvesicles (50-1000 nm), apoptotic bodies (50-5000 nm) and exosomes (30-150 nm), based on distinct biogenesis pathways. Microvesicles are formed by direct budding of the plasma membrane, in which ARF6 and RhoA are important regulators. In addition, oncosomes are also a kind of microvesicles, which are specifically released by tumor cells and contain many specific molecules of tumor cells. When cells undergo apoptosis, they could also release a population of EVs called apoptotic bodies. This kind of EVs is formed through outward blebbing and fragmentation of the cell membrane. Exosomes are derived from multivesicular bodies (MVBs), and released by cells upon fusion of MVBs with the plasma membrane. Exosomes have complex formation and regulatory mechanisms, including endosomal sorting complex dependent and non-dependent mechanisms. Many researchers have shown that EVs with different types and different cell sources may have different components and functions. EVs mainly carry the bioactive molecules of donor cells, such as proteins, DNA or RNA, and target nearby or remote cells to perform different biological functions, thus affecting the physiological and pathological processes of recipient cells. Cells can also discharge their waste by EVs. By transporting cargoes to extracellular, EVs can regulate the amount of intracellular cargoes, thus affecting the survival status of cells. This approach can be beneficial to cells (removing harmful substances) or harmful (transporting drugs outside the cell). Secondly, some key molecules in EVs can be regulated by donor cells according to their state. So, EVs can also reflect the state changes of donor cells, and have the potential as a biomarker for the diagnosis and treatment of diseases. Due to their stable existence in body fluids and derived from various tissues of the body, EVs can not only be a new biomarker of liquid biopsy, but also reflect the heterogeneity and the genesis or development of diseases. As a natural endogenous material, EVs can also serve as a potential drug delivery carrier, and have the advantages of low immunogenicity and crossing the blood brain barrier. In addition, EVs have many other applications. For example, they can be an alternative to cells as a therapeutic agent, as well as targets of disease treatment. This review summarizes the following parts: Firstly, biological origin, biological composition, biological characteristics, and biological functions of EVs. Secondly, the isolation and characterization of EVs. Thirdly, the application of EVs in the diagnosis and treatment of diseases were introduced. At present, the heterogeneity, biological composition and the formation mechanism of EVs need to be further studied, so that it can be better applied in the diagnosis and treatment of diseases. The effective isolation method is also necessary for its clinical application. It is believed that with the development of various biological technologies, these problems will be gradually solved, the biological function of EVs will be also clearly understood, and EVs based application in diseases will make new breakthroughs.

Research progress in in vivo tracing technology for extracellular vesicles

In Vivo Imaging for the Visualization of Extracellular Vesicle‐Based Tumor Therapy

Current Perspectives on In Vivo Noninvasive Tracking of Extracellular Vesicles with Molecular Imaging

Unveiling Invisible Extracellular Vesicles: Cutting-Edge Technologies for Their in Vivo Visualization

Emerging strategies for labeling and tracking of extracellular vesicles

An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles

Imaging extracellular vesicles: current and emerging methods

Extracellular Vesicles and Intercellular Communication: Challenges for In Vivo Molecular Imaging and Tracking

Extracellular vesicles: Emerging tools as therapeutic agent carriers

Theranostic extracellular vesicles: a concise review of current imaging technologies and labeling strategies

The Role of Extracellular Vesicles in Tumor Therapy and Imaging

Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution in Vivo

The power of imaging to understand extracellular vesicle biology in vivo

Extracellular Vesicles and Their Application in the Diagnosis and Treatment of Diseases

Current Progression in Application of Extracellular Vesicles in Central Nervous System Diseases

Advances in extracellular vesicles analysis

Analysis of extracellular vesicles as emerging theranostic nanoplatforms

Recent advances in single extracellular vesicle detection methods

Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics

Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging

In Vivo Visualized Tracking of Tumor-Derived Extracellular Vesicles Using CRISPR-Cas9 System.